Home > > > > Report Detail

Global Opioid-Induced Constipation Market Research Report 2022 Professional Edition

Publisher Name :
Date: 06-Jan-2022
No. of pages: 134

The global Opioid-Induced Constipation market was valued at 208.89 Million USD in 2021 and will grow with a CAGR of 4.95% from 2021 to 2027, based on HNY Research newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

Opioids are administered to the patients with acute and non-cancer chronic pain. They have several adverse gastrointestinal effects, one of which is opioid-induced constipation. Opioids are administered to the patients with acute and non-cancer chronic pain. They have several adverse gastrointestinal effects, one of which is opioid-induced constipation.Opioid-Induced Constipation is widely sold in Hospital, Pharmacy and other field. The most proportion of Opioid-Induced Constipation is sold in Pharmacy, and the proportion in 2017 is 45.99%. North America is the largest Sales place, with a Sales market share nearly 56.48% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 20.49%.

By Market Verdors:

Takeda Pharmaceuticals

Bayer

Sanofi

Mallinckrodt

Salix (Bausch Health)

AstraZeneca

Progenics Pharmaceuticals

Purdue Pharm

Nektar Therapeutics

Daiichi Sankyo

Prestige

GSK

Shionogi

By Types:

Methylnaltrexone Bromide

Lubiprostone

Naloxegol

By Applications:

Hospital

Pharmacy

Key Indicators Analysed

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market Trends: Market key trends which include Increased Competition and Continuous Innovations.

Opportunities and Drivers: Identifying the Growing Demands and New Technology

Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements

Global Opioid-Induced Constipation Market Research Report 2022 Professional Edition

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Opioid-Induced Constipation Revenue
1.4 Market Analysis by Type
1.4.1 Global Opioid-Induced Constipation Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Methylnaltrexone Bromide
1.4.3 Lubiprostone
1.4.4 Naloxegol
1.5 Market by Application
1.5.1 Global Opioid-Induced Constipation Market Share by Application: 2022-2027
1.5.2 Hospital
1.5.3 Pharmacy
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Opioid-Induced Constipation Market
1.8.1 Global Opioid-Induced Constipation Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Opioid-Induced Constipation Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Opioid-Induced Constipation Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Opioid-Induced Constipation Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Opioid-Induced Constipation Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Opioid-Induced Constipation Sales Volume Market Share by Region (2016-2021)
3.2 Global Opioid-Induced Constipation Sales Revenue Market Share by Region (2016-2021)
3.3 North America Opioid-Induced Constipation Sales Volume
3.3.1 North America Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
3.3.2 North America Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Opioid-Induced Constipation Sales Volume
3.4.1 East Asia Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Opioid-Induced Constipation Sales Volume (2016-2021)
3.5.1 Europe Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Opioid-Induced Constipation Sales Volume (2016-2021)
3.6.1 South Asia Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Opioid-Induced Constipation Sales Volume (2016-2021)
3.7.1 Southeast Asia Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Opioid-Induced Constipation Sales Volume (2016-2021)
3.8.1 Middle East Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Opioid-Induced Constipation Sales Volume (2016-2021)
3.9.1 Africa Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Opioid-Induced Constipation Sales Volume (2016-2021)
3.10.1 Oceania Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Opioid-Induced Constipation Sales Volume (2016-2021)
3.11.1 South America Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
3.11.2 South America Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Opioid-Induced Constipation Sales Volume (2016-2021)
3.12.1 Rest of the World Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Opioid-Induced Constipation Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Opioid-Induced Constipation Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Opioid-Induced Constipation Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Opioid-Induced Constipation Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Opioid-Induced Constipation Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Opioid-Induced Constipation Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Opioid-Induced Constipation Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Opioid-Induced Constipation Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Opioid-Induced Constipation Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Opioid-Induced Constipation Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Opioid-Induced Constipation Sales Volume Market Share by Type (2016-2021)
14.2 Global Opioid-Induced Constipation Sales Revenue Market Share by Type (2016-2021)
14.3 Global Opioid-Induced Constipation Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Opioid-Induced Constipation Consumption Volume by Application (2016-2021)
15.2 Global Opioid-Induced Constipation Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Opioid-Induced Constipation Business
16.1 Takeda Pharmaceuticals
16.1.1 Takeda Pharmaceuticals Company Profile
16.1.2 Takeda Pharmaceuticals Opioid-Induced Constipation Product Specification
16.1.3 Takeda Pharmaceuticals Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Bayer
16.2.1 Bayer Company Profile
16.2.2 Bayer Opioid-Induced Constipation Product Specification
16.2.3 Bayer Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Sanofi
16.3.1 Sanofi Company Profile
16.3.2 Sanofi Opioid-Induced Constipation Product Specification
16.3.3 Sanofi Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Mallinckrodt
16.4.1 Mallinckrodt Company Profile
16.4.2 Mallinckrodt Opioid-Induced Constipation Product Specification
16.4.3 Mallinckrodt Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Salix (Bausch Health)
16.5.1 Salix (Bausch Health) Company Profile
16.5.2 Salix (Bausch Health) Opioid-Induced Constipation Product Specification
16.5.3 Salix (Bausch Health) Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 AstraZeneca
16.6.1 AstraZeneca Company Profile
16.6.2 AstraZeneca Opioid-Induced Constipation Product Specification
16.6.3 AstraZeneca Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Progenics Pharmaceuticals
16.7.1 Progenics Pharmaceuticals Company Profile
16.7.2 Progenics Pharmaceuticals Opioid-Induced Constipation Product Specification
16.7.3 Progenics Pharmaceuticals Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Purdue Pharm
16.8.1 Purdue Pharm Company Profile
16.8.2 Purdue Pharm Opioid-Induced Constipation Product Specification
16.8.3 Purdue Pharm Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Nektar Therapeutics
16.9.1 Nektar Therapeutics Company Profile
16.9.2 Nektar Therapeutics Opioid-Induced Constipation Product Specification
16.9.3 Nektar Therapeutics Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Daiichi Sankyo
16.10.1 Daiichi Sankyo Company Profile
16.10.2 Daiichi Sankyo Opioid-Induced Constipation Product Specification
16.10.3 Daiichi Sankyo Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Prestige
16.11.1 Prestige Company Profile
16.11.2 Prestige Opioid-Induced Constipation Product Specification
16.11.3 Prestige Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 GSK
16.12.1 GSK Company Profile
16.12.2 GSK Opioid-Induced Constipation Product Specification
16.12.3 GSK Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Shionogi
16.13.1 Shionogi Company Profile
16.13.2 Shionogi Opioid-Induced Constipation Product Specification
16.13.3 Shionogi Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Opioid-Induced Constipation Manufacturing Cost Analysis
17.1 Opioid-Induced Constipation Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Opioid-Induced Constipation
17.4 Opioid-Induced Constipation Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Opioid-Induced Constipation Distributors List
18.3 Opioid-Induced Constipation Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Opioid-Induced Constipation (2022-2027)
20.2 Global Forecasted Revenue of Opioid-Induced Constipation (2022-2027)
20.3 Global Forecasted Price of Opioid-Induced Constipation (2016-2027)
20.4 Global Forecasted Production of Opioid-Induced Constipation by Region (2022-2027)
20.4.1 North America Opioid-Induced Constipation Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Opioid-Induced Constipation Production, Revenue Forecast (2022-2027)
20.4.3 Europe Opioid-Induced Constipation Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Opioid-Induced Constipation Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Opioid-Induced Constipation Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Opioid-Induced Constipation Production, Revenue Forecast (2022-2027)
20.4.7 Africa Opioid-Induced Constipation Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Opioid-Induced Constipation Production, Revenue Forecast (2022-2027)
20.4.9 South America Opioid-Induced Constipation Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Opioid-Induced Constipation Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Opioid-Induced Constipation by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Opioid-Induced Constipation by Country
21.2 East Asia Market Forecasted Consumption of Opioid-Induced Constipation by Country
21.3 Europe Market Forecasted Consumption of Opioid-Induced Constipation by Countriy
21.4 South Asia Forecasted Consumption of Opioid-Induced Constipation by Country
21.5 Southeast Asia Forecasted Consumption of Opioid-Induced Constipation by Country
21.6 Middle East Forecasted Consumption of Opioid-Induced Constipation by Country
21.7 Africa Forecasted Consumption of Opioid-Induced Constipation by Country
21.8 Oceania Forecasted Consumption of Opioid-Induced Constipation by Country
21.9 South America Forecasted Consumption of Opioid-Induced Constipation by Country
21.10 Rest of the world Forecasted Consumption of Opioid-Induced Constipation by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer

List of Tables and Figures

Key Players Covered: Ranking by Opioid-Induced Constipation Revenue (US$ Million) 2016-2021
Global Opioid-Induced Constipation Market Size by Type (US$ Million): 2022-2027
Global Opioid-Induced Constipation Market Size by Application (US$ Million): 2022-2027
Global Opioid-Induced Constipation Production Capacity by Manufacturers
Global Opioid-Induced Constipation Production by Manufacturers (2016-2021)
Global Opioid-Induced Constipation Production Market Share by Manufacturers (2016-2021)
Global Opioid-Induced Constipation Revenue by Manufacturers (2016-2021)
Global Opioid-Induced Constipation Revenue Share by Manufacturers (2016-2021)
Global Market Opioid-Induced Constipation Average Price of Key Manufacturers (2016-2021)
Manufacturers Opioid-Induced Constipation Production Sites and Area Served
Manufacturers Opioid-Induced Constipation Product Type
Global Opioid-Induced Constipation Sales Volume by Region (2016-2021)
Global Opioid-Induced Constipation Sales Volume Market Share by Region (2016-2021)
Global Opioid-Induced Constipation Sales Revenue by Region (2016-2021)
Global Opioid-Induced Constipation Sales Revenue Market Share by Region (2016-2021)
North America Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
East Asia Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Europe Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South Asia Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Southeast Asia Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Middle East Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Africa Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Oceania Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South America Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Rest of the World Opioid-Induced Constipation Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
North America Opioid-Induced Constipation Consumption by Countries (2016-2021)
East Asia Opioid-Induced Constipation Consumption by Countries (2016-2021)
Europe Opioid-Induced Constipation Consumption by Region (2016-2021)
South Asia Opioid-Induced Constipation Consumption by Countries (2016-2021)
Southeast Asia Opioid-Induced Constipation Consumption by Countries (2016-2021)
Middle East Opioid-Induced Constipation Consumption by Countries (2016-2021)
Africa Opioid-Induced Constipation Consumption by Countries (2016-2021)
Oceania Opioid-Induced Constipation Consumption by Countries (2016-2021)
South America Opioid-Induced Constipation Consumption by Countries (2016-2021)
Rest of the World Opioid-Induced Constipation Consumption by Countries (2016-2021)
Global Opioid-Induced Constipation Sales Volume by Type (2016-2021)
Global Opioid-Induced Constipation Sales Volume Market Share by Type (2016-2021)
Global Opioid-Induced Constipation Sales Revenue by Type (2016-2021)
Global Opioid-Induced Constipation Sales Revenue Share by Type (2016-2021)
Global Opioid-Induced Constipation Sales Price by Type (2016-2021)
Global Opioid-Induced Constipation Consumption Volume by Application (2016-2021)
Global Opioid-Induced Constipation Consumption Volume Market Share by Application (2016-2021)
Global Opioid-Induced Constipation Consumption Value by Application (2016-2021)
Global Opioid-Induced Constipation Consumption Value Market Share by Application (2016-2021)
Takeda Pharmaceuticals Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Bayer Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Sanofi Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table Mallinckrodt Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Salix (Bausch Health) Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
AstraZeneca Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Progenics Pharmaceuticals Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Purdue Pharm Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Nektar Therapeutics Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Daiichi Sankyo Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Prestige Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
GSK Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Shionogi Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Opioid-Induced Constipation Distributors List
Opioid-Induced Constipation Customers List
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2022-2027)
Key Challenges
Global Opioid-Induced Constipation Production Forecast by Region (2022-2027)
Global Opioid-Induced Constipation Sales Volume Forecast by Type (2022-2027)
Global Opioid-Induced Constipation Sales Volume Market Share Forecast by Type (2022-2027)
Global Opioid-Induced Constipation Sales Revenue Forecast by Type (2022-2027)
Global Opioid-Induced Constipation Sales Revenue Market Share Forecast by Type (2022-2027)
Global Opioid-Induced Constipation Sales Price Forecast by Type (2022-2027)
Global Opioid-Induced Constipation Consumption Volume Forecast by Application (2022-2027)
Global Opioid-Induced Constipation Consumption Value Forecast by Application (2022-2027)
North America Opioid-Induced Constipation Consumption Forecast 2022-2027 by Country
East Asia Opioid-Induced Constipation Consumption Forecast 2022-2027 by Country
Europe Opioid-Induced Constipation Consumption Forecast 2022-2027 by Country
South Asia Opioid-Induced Constipation Consumption Forecast 2022-2027 by Country
Southeast Asia Opioid-Induced Constipation Consumption Forecast 2022-2027 by Country
Middle East Opioid-Induced Constipation Consumption Forecast 2022-2027 by Country
Africa Opioid-Induced Constipation Consumption Forecast 2022-2027 by Country
Oceania Opioid-Induced Constipation Consumption Forecast 2022-2027 by Country
South America Opioid-Induced Constipation Consumption Forecast 2022-2027 by Country
Rest of the world Opioid-Induced Constipation Consumption Forecast 2022-2027 by Country
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources


Global Opioid-Induced Constipation Market Share by Type: 2021 VS 2027
Methylnaltrexone Bromide Features
Lubiprostone Features
Naloxegol Features
Global Opioid-Induced Constipation Market Share by Application: 2021 VS 2027
Hospital Case Studies
Pharmacy Case Studies
Opioid-Induced Constipation Report Years Considered
Global Opioid-Induced Constipation Market Status and Outlook (2016-2027)
North America Opioid-Induced Constipation Revenue (Value) and Growth Rate (2016-2027)
East Asia Opioid-Induced Constipation Revenue (Value) and Growth Rate (2016-2027)
Europe Opioid-Induced Constipation Revenue (Value) and Growth Rate (2016-2027)
South Asia Opioid-Induced Constipation Revenue (Value) and Growth Rate (2016-2027)
South America Opioid-Induced Constipation Revenue (Value) and Growth Rate (2016-2027)
Middle East Opioid-Induced Constipation Revenue (Value) and Growth Rate (2016-2027)
Africa Opioid-Induced Constipation Revenue (Value) and Growth Rate (2016-2027)
Oceania Opioid-Induced Constipation Revenue (Value) and Growth Rate (2016-2027)
South America Opioid-Induced Constipation Revenue (Value) and Growth Rate (2016-2027)
Rest of the World Opioid-Induced Constipation Revenue (Value) and Growth Rate (2016-2027)
North America Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
East Asia Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
Europe Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
South Asia Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
Southeast Asia Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
Middle East Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
Africa Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
Oceania Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
South America Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
Rest of the World Opioid-Induced Constipation Sales Volume Growth Rate (2016-2021)
North America Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
North America Opioid-Induced Constipation Consumption Market Share by Countries in 2021
United States Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Canada Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Mexico Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
East Asia Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
East Asia Opioid-Induced Constipation Consumption Market Share by Countries in 2021
China Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Japan Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
South Korea Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Europe Opioid-Induced Constipation Consumption and Growth Rate
Europe Opioid-Induced Constipation Consumption Market Share by Region in 2021
Germany Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
United Kingdom Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
France Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Italy Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Russia Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Spain Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Netherlands Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Switzerland Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Poland Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
South Asia Opioid-Induced Constipation Consumption and Growth Rate
South Asia Opioid-Induced Constipation Consumption Market Share by Countries in 2021
India Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Pakistan Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Bangladesh Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Southeast Asia Opioid-Induced Constipation Consumption and Growth Rate
Southeast Asia Opioid-Induced Constipation Consumption Market Share by Countries in 2021
Indonesia Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Thailand Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Singapore Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Malaysia Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Philippines Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Vietnam Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Myanmar Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Middle East Opioid-Induced Constipation Consumption and Growth Rate
Middle East Opioid-Induced Constipation Consumption Market Share by Countries in 2021
Turkey Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Saudi Arabia Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Iran Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
United Arab Emirates Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Israel Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Iraq Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Qatar Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Kuwait Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Oman Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Africa Opioid-Induced Constipation Consumption and Growth Rate
Africa Opioid-Induced Constipation Consumption Market Share by Countries in 2021
Nigeria Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
South Africa Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Egypt Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Algeria Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Morocco Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Oceania Opioid-Induced Constipation Consumption and Growth Rate
Oceania Opioid-Induced Constipation Consumption Market Share by Countries in 2021
Australia Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
New Zealand Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
South America Opioid-Induced Constipation Consumption and Growth Rate
South America Opioid-Induced Constipation Consumption Market Share by Countries in 2021
Brazil Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Argentina Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Columbia Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Chile Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Venezuelal Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Peru Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Puerto Rico Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Ecuador Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Rest of the World Opioid-Induced Constipation Consumption and Growth Rate
Rest of the World Opioid-Induced Constipation Consumption Market Share by Countries in 2021
Kazakhstan Opioid-Induced Constipation Consumption and Growth Rate (2016-2021)
Sales Market Share of Opioid-Induced Constipation by Type in 2021
Sales Revenue Market Share of Opioid-Induced Constipation by Type in 2021
Global Opioid-Induced Constipation Consumption Volume Market Share by Application in 2021
Takeda Pharmaceuticals Opioid-Induced Constipation Product Specification
Bayer Opioid-Induced Constipation Product Specification
Sanofi Opioid-Induced Constipation Product Specification
Mallinckrodt Opioid-Induced Constipation Product Specification
Salix (Bausch Health) Opioid-Induced Constipation Product Specification
AstraZeneca Opioid-Induced Constipation Product Specification
Progenics Pharmaceuticals Opioid-Induced Constipation Product Specification
Purdue Pharm Opioid-Induced Constipation Product Specification
Nektar Therapeutics Opioid-Induced Constipation Product Specification
Daiichi Sankyo Opioid-Induced Constipation Product Specification
Prestige Opioid-Induced Constipation Product Specification
GSK Opioid-Induced Constipation Product Specification
Shionogi Opioid-Induced Constipation Product Specification
Manufacturing Cost Structure of Opioid-Induced Constipation
Manufacturing Process Analysis of Opioid-Induced Constipation
Opioid-Induced Constipation Industrial Chain Analysis
Channels of Distribution
Distributors Profiles
Porter's Five Forces Analysis
Global Opioid-Induced Constipation Production Capacity Growth Rate Forecast (2022-2027)
Global Opioid-Induced Constipation Revenue Growth Rate Forecast (2022-2027)
Global Opioid-Induced Constipation Price and Trend Forecast (2016-2027)
North America Opioid-Induced Constipation Production Growth Rate Forecast (2022-2027)
North America Opioid-Induced Constipation Revenue Growth Rate Forecast (2022-2027)
East Asia Opioid-Induced Constipation Production Growth Rate Forecast (2022-2027)
East Asia Opioid-Induced Constipation Revenue Growth Rate Forecast (2022-2027)
Europe Opioid-Induced Constipation Production Growth Rate Forecast (2022-2027)
Europe Opioid-Induced Constipation Revenue Growth Rate Forecast (2022-2027)
South Asia Opioid-Induced Constipation Production Growth Rate Forecast (2022-2027)
South Asia Opioid-Induced Constipation Revenue Growth Rate Forecast (2022-2027)
Southeast Asia Opioid-Induced Constipation Production Growth Rate Forecast (2022-2027)
Southeast Asia Opioid-Induced Constipation Revenue Growth Rate Forecast (2022-2027)
Middle East Opioid-Induced Constipation Production Growth Rate Forecast (2022-2027)
Middle East Opioid-Induced Constipation Revenue Growth Rate Forecast (2022-2027)
Africa Opioid-Induced Constipation Production Growth Rate Forecast (2022-2027)
Africa Opioid-Induced Constipation Revenue Growth Rate Forecast (2022-2027)
Oceania Opioid-Induced Constipation Production Growth Rate Forecast (2022-2027)
Oceania Opioid-Induced Constipation Revenue Growth Rate Forecast (2022-2027)
South America Opioid-Induced Constipation Production Growth Rate Forecast (2022-2027)
South America Opioid-Induced Constipation Revenue Growth Rate Forecast (2022-2027)
Rest of the World Opioid-Induced Constipation Production Growth Rate Forecast (2022-2027)
Rest of the World Opioid-Induced Constipation Revenue Growth Rate Forecast (2022-2027)
North America Opioid-Induced Constipation Consumption Forecast 2022-2027
East Asia Opioid-Induced Constipation Consumption Forecast 2022-2027
Europe Opioid-Induced Constipation Consumption Forecast 2022-2027
South Asia Opioid-Induced Constipation Consumption Forecast 2022-2027
Southeast Asia Opioid-Induced Constipation Consumption Forecast 2022-2027
Middle East Opioid-Induced Constipation Consumption Forecast 2022-2027
Africa Opioid-Induced Constipation Consumption Forecast 2022-2027
Oceania Opioid-Induced Constipation Consumption Forecast 2022-2027
South America Opioid-Induced Constipation Consumption Forecast 2022-2027
Rest of the world Opioid-Induced Constipation Consumption Forecast 2022-2027
Bottom-up and Top-down Approaches for This Report

  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs